J AM COLL CARDIOL 润色咨询

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

出版年份:1983 年文章数:5193 投稿命中率: 开通期刊会员,数据随心看

出版周期:Weekly 自引率:6.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=536282, encodeId=8a81536282d4, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇,审稿一个月,三个审稿意见,均为小修。希望能接受!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3582, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78021615620, createdName=xibo2007, createdTime=Tue May 02 22:30:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529256, encodeId=57065292567f, content=接受了吗?<span class="quote">yanyinkun 2015-07-21 发表::<br>研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!</span>, beContent=yanyinkun 2015-07-21 发表:: 研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Nov 12 12:53:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522496, encodeId=755452249678, content=审稿速度:1.0<br>经验分享:大牛杂志,提了一堆修改意见,之后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Tue May 17 02:05:00 CST 2016, time=2016-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831968, encodeId=025c831968b5, content=审稿速度:1.0<br>经验分享:在这个期刊已经接受了两篇,还有一篇小修,感觉办事效率很高,基本两星期审稿意见回来,修改后基本一周内接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Apr 14 10:50:43 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519202, encodeId=2ed251920296, content=你是幸运儿之一吗?<span class="quote">mileo 2015-11-20 发表::<br>接受率大概多少?好像是10%左右吧。。</span>, beContent=mileo 2015-11-20 发表:: 接受率大概多少?好像是10%左右吧。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Mon Feb 15 09:02:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516955, encodeId=2709516955fb, content=接受率大概多少?好像是10%左右吧。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Fri Nov 20 01:16:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513707, encodeId=b01c513e0716, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿50天,还在under review. 估计该回信了,着急啊!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c4a23377, createdName=yanyinkun, createdTime=Tue Jul 21 22:01:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513632, encodeId=eddd51363295, content=投稿命中率:5.0<br>经验分享:投了Circulationb被拒,改投JACC,有关心肌停跳液心肌保护的回顾性和随访研究,审稿一个多月,两个审稿人均拒绝了,文章创新性不够,说现在北美流行的是 del Nido液,为何不比较HTK和del Nido液的临床结果?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=677, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Jul 18 22:26:00 CST 2015, time=2015-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510801, encodeId=e86851080124, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇文章,审了26天,被拒,但审稿意见非常细,非常有用,建议时间不紧张的可以多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat Mar 28 20:55:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503572, encodeId=8de25035e24b, content=投了一篇 审稿47天了 怎么变得这么慢了 忐忑中,,不是一个月就有结果吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a97104148, createdName=yufeng00000, createdTime=Sun Jun 15 17:42:00 CST 2014, time=2014-06-15, status=1, ipAttribution=)]
    2017-05-02 xibo2007

    审稿速度:1.0 | 投稿命中率:5.0
    经验分享:投了一篇,审稿一个月,三个审稿意见,均为小修。希望能接受!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=536282, encodeId=8a81536282d4, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇,审稿一个月,三个审稿意见,均为小修。希望能接受!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3582, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78021615620, createdName=xibo2007, createdTime=Tue May 02 22:30:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529256, encodeId=57065292567f, content=接受了吗?<span class="quote">yanyinkun 2015-07-21 发表::<br>研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!</span>, beContent=yanyinkun 2015-07-21 发表:: 研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Nov 12 12:53:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522496, encodeId=755452249678, content=审稿速度:1.0<br>经验分享:大牛杂志,提了一堆修改意见,之后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Tue May 17 02:05:00 CST 2016, time=2016-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831968, encodeId=025c831968b5, content=审稿速度:1.0<br>经验分享:在这个期刊已经接受了两篇,还有一篇小修,感觉办事效率很高,基本两星期审稿意见回来,修改后基本一周内接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Apr 14 10:50:43 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519202, encodeId=2ed251920296, content=你是幸运儿之一吗?<span class="quote">mileo 2015-11-20 发表::<br>接受率大概多少?好像是10%左右吧。。</span>, beContent=mileo 2015-11-20 发表:: 接受率大概多少?好像是10%左右吧。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Mon Feb 15 09:02:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516955, encodeId=2709516955fb, content=接受率大概多少?好像是10%左右吧。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Fri Nov 20 01:16:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513707, encodeId=b01c513e0716, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿50天,还在under review. 估计该回信了,着急啊!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c4a23377, createdName=yanyinkun, createdTime=Tue Jul 21 22:01:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513632, encodeId=eddd51363295, content=投稿命中率:5.0<br>经验分享:投了Circulationb被拒,改投JACC,有关心肌停跳液心肌保护的回顾性和随访研究,审稿一个多月,两个审稿人均拒绝了,文章创新性不够,说现在北美流行的是 del Nido液,为何不比较HTK和del Nido液的临床结果?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=677, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Jul 18 22:26:00 CST 2015, time=2015-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510801, encodeId=e86851080124, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇文章,审了26天,被拒,但审稿意见非常细,非常有用,建议时间不紧张的可以多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat Mar 28 20:55:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503572, encodeId=8de25035e24b, content=投了一篇 审稿47天了 怎么变得这么慢了 忐忑中,,不是一个月就有结果吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a97104148, createdName=yufeng00000, createdTime=Sun Jun 15 17:42:00 CST 2014, time=2014-06-15, status=1, ipAttribution=)]
    2016-11-12 qqd140d1b8

    接受了吗?yanyinkun 2015-07-21 发表::
    研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!

    yanyinkun 2015-07-21 发表:: 研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=536282, encodeId=8a81536282d4, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇,审稿一个月,三个审稿意见,均为小修。希望能接受!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3582, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78021615620, createdName=xibo2007, createdTime=Tue May 02 22:30:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529256, encodeId=57065292567f, content=接受了吗?<span class="quote">yanyinkun 2015-07-21 发表::<br>研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!</span>, beContent=yanyinkun 2015-07-21 发表:: 研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Nov 12 12:53:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522496, encodeId=755452249678, content=审稿速度:1.0<br>经验分享:大牛杂志,提了一堆修改意见,之后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Tue May 17 02:05:00 CST 2016, time=2016-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831968, encodeId=025c831968b5, content=审稿速度:1.0<br>经验分享:在这个期刊已经接受了两篇,还有一篇小修,感觉办事效率很高,基本两星期审稿意见回来,修改后基本一周内接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Apr 14 10:50:43 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519202, encodeId=2ed251920296, content=你是幸运儿之一吗?<span class="quote">mileo 2015-11-20 发表::<br>接受率大概多少?好像是10%左右吧。。</span>, beContent=mileo 2015-11-20 发表:: 接受率大概多少?好像是10%左右吧。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Mon Feb 15 09:02:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516955, encodeId=2709516955fb, content=接受率大概多少?好像是10%左右吧。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Fri Nov 20 01:16:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513707, encodeId=b01c513e0716, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿50天,还在under review. 估计该回信了,着急啊!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c4a23377, createdName=yanyinkun, createdTime=Tue Jul 21 22:01:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513632, encodeId=eddd51363295, content=投稿命中率:5.0<br>经验分享:投了Circulationb被拒,改投JACC,有关心肌停跳液心肌保护的回顾性和随访研究,审稿一个多月,两个审稿人均拒绝了,文章创新性不够,说现在北美流行的是 del Nido液,为何不比较HTK和del Nido液的临床结果?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=677, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Jul 18 22:26:00 CST 2015, time=2015-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510801, encodeId=e86851080124, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇文章,审了26天,被拒,但审稿意见非常细,非常有用,建议时间不紧张的可以多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat Mar 28 20:55:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503572, encodeId=8de25035e24b, content=投了一篇 审稿47天了 怎么变得这么慢了 忐忑中,,不是一个月就有结果吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a97104148, createdName=yufeng00000, createdTime=Sun Jun 15 17:42:00 CST 2014, time=2014-06-15, status=1, ipAttribution=)]
    2016-05-17 arlian1977

    审稿速度:1.0
    经验分享:大牛杂志,提了一堆修改意见,之后被拒

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=536282, encodeId=8a81536282d4, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇,审稿一个月,三个审稿意见,均为小修。希望能接受!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3582, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78021615620, createdName=xibo2007, createdTime=Tue May 02 22:30:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529256, encodeId=57065292567f, content=接受了吗?<span class="quote">yanyinkun 2015-07-21 发表::<br>研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!</span>, beContent=yanyinkun 2015-07-21 发表:: 研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Nov 12 12:53:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522496, encodeId=755452249678, content=审稿速度:1.0<br>经验分享:大牛杂志,提了一堆修改意见,之后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Tue May 17 02:05:00 CST 2016, time=2016-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831968, encodeId=025c831968b5, content=审稿速度:1.0<br>经验分享:在这个期刊已经接受了两篇,还有一篇小修,感觉办事效率很高,基本两星期审稿意见回来,修改后基本一周内接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Apr 14 10:50:43 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519202, encodeId=2ed251920296, content=你是幸运儿之一吗?<span class="quote">mileo 2015-11-20 发表::<br>接受率大概多少?好像是10%左右吧。。</span>, beContent=mileo 2015-11-20 发表:: 接受率大概多少?好像是10%左右吧。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Mon Feb 15 09:02:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516955, encodeId=2709516955fb, content=接受率大概多少?好像是10%左右吧。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Fri Nov 20 01:16:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513707, encodeId=b01c513e0716, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿50天,还在under review. 估计该回信了,着急啊!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c4a23377, createdName=yanyinkun, createdTime=Tue Jul 21 22:01:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513632, encodeId=eddd51363295, content=投稿命中率:5.0<br>经验分享:投了Circulationb被拒,改投JACC,有关心肌停跳液心肌保护的回顾性和随访研究,审稿一个多月,两个审稿人均拒绝了,文章创新性不够,说现在北美流行的是 del Nido液,为何不比较HTK和del Nido液的临床结果?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=677, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Jul 18 22:26:00 CST 2015, time=2015-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510801, encodeId=e86851080124, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇文章,审了26天,被拒,但审稿意见非常细,非常有用,建议时间不紧张的可以多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat Mar 28 20:55:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503572, encodeId=8de25035e24b, content=投了一篇 审稿47天了 怎么变得这么慢了 忐忑中,,不是一个月就有结果吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a97104148, createdName=yufeng00000, createdTime=Sun Jun 15 17:42:00 CST 2014, time=2014-06-15, status=1, ipAttribution=)]
    2016-04-14 ms8494960720180498

    审稿速度:1.0
    经验分享:在这个期刊已经接受了两篇,还有一篇小修,感觉办事效率很高,基本两星期审稿意见回来,修改后基本一周内接受

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=536282, encodeId=8a81536282d4, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇,审稿一个月,三个审稿意见,均为小修。希望能接受!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3582, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78021615620, createdName=xibo2007, createdTime=Tue May 02 22:30:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529256, encodeId=57065292567f, content=接受了吗?<span class="quote">yanyinkun 2015-07-21 发表::<br>研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!</span>, beContent=yanyinkun 2015-07-21 发表:: 研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Nov 12 12:53:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522496, encodeId=755452249678, content=审稿速度:1.0<br>经验分享:大牛杂志,提了一堆修改意见,之后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Tue May 17 02:05:00 CST 2016, time=2016-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831968, encodeId=025c831968b5, content=审稿速度:1.0<br>经验分享:在这个期刊已经接受了两篇,还有一篇小修,感觉办事效率很高,基本两星期审稿意见回来,修改后基本一周内接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Apr 14 10:50:43 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519202, encodeId=2ed251920296, content=你是幸运儿之一吗?<span class="quote">mileo 2015-11-20 发表::<br>接受率大概多少?好像是10%左右吧。。</span>, beContent=mileo 2015-11-20 发表:: 接受率大概多少?好像是10%左右吧。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Mon Feb 15 09:02:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516955, encodeId=2709516955fb, content=接受率大概多少?好像是10%左右吧。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Fri Nov 20 01:16:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513707, encodeId=b01c513e0716, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿50天,还在under review. 估计该回信了,着急啊!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c4a23377, createdName=yanyinkun, createdTime=Tue Jul 21 22:01:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513632, encodeId=eddd51363295, content=投稿命中率:5.0<br>经验分享:投了Circulationb被拒,改投JACC,有关心肌停跳液心肌保护的回顾性和随访研究,审稿一个多月,两个审稿人均拒绝了,文章创新性不够,说现在北美流行的是 del Nido液,为何不比较HTK和del Nido液的临床结果?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=677, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Jul 18 22:26:00 CST 2015, time=2015-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510801, encodeId=e86851080124, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇文章,审了26天,被拒,但审稿意见非常细,非常有用,建议时间不紧张的可以多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat Mar 28 20:55:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503572, encodeId=8de25035e24b, content=投了一篇 审稿47天了 怎么变得这么慢了 忐忑中,,不是一个月就有结果吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a97104148, createdName=yufeng00000, createdTime=Sun Jun 15 17:42:00 CST 2014, time=2014-06-15, status=1, ipAttribution=)]
    2016-02-15 pangshiwei

    你是幸运儿之一吗?mileo 2015-11-20 发表::
    接受率大概多少?好像是10%左右吧。。

    mileo 2015-11-20 发表:: 接受率大概多少?好像是10%左右吧。。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=536282, encodeId=8a81536282d4, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇,审稿一个月,三个审稿意见,均为小修。希望能接受!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3582, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78021615620, createdName=xibo2007, createdTime=Tue May 02 22:30:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529256, encodeId=57065292567f, content=接受了吗?<span class="quote">yanyinkun 2015-07-21 发表::<br>研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!</span>, beContent=yanyinkun 2015-07-21 发表:: 研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Nov 12 12:53:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522496, encodeId=755452249678, content=审稿速度:1.0<br>经验分享:大牛杂志,提了一堆修改意见,之后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Tue May 17 02:05:00 CST 2016, time=2016-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831968, encodeId=025c831968b5, content=审稿速度:1.0<br>经验分享:在这个期刊已经接受了两篇,还有一篇小修,感觉办事效率很高,基本两星期审稿意见回来,修改后基本一周内接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Apr 14 10:50:43 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519202, encodeId=2ed251920296, content=你是幸运儿之一吗?<span class="quote">mileo 2015-11-20 发表::<br>接受率大概多少?好像是10%左右吧。。</span>, beContent=mileo 2015-11-20 发表:: 接受率大概多少?好像是10%左右吧。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Mon Feb 15 09:02:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516955, encodeId=2709516955fb, content=接受率大概多少?好像是10%左右吧。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Fri Nov 20 01:16:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513707, encodeId=b01c513e0716, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿50天,还在under review. 估计该回信了,着急啊!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c4a23377, createdName=yanyinkun, createdTime=Tue Jul 21 22:01:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513632, encodeId=eddd51363295, content=投稿命中率:5.0<br>经验分享:投了Circulationb被拒,改投JACC,有关心肌停跳液心肌保护的回顾性和随访研究,审稿一个多月,两个审稿人均拒绝了,文章创新性不够,说现在北美流行的是 del Nido液,为何不比较HTK和del Nido液的临床结果?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=677, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Jul 18 22:26:00 CST 2015, time=2015-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510801, encodeId=e86851080124, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇文章,审了26天,被拒,但审稿意见非常细,非常有用,建议时间不紧张的可以多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat Mar 28 20:55:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503572, encodeId=8de25035e24b, content=投了一篇 审稿47天了 怎么变得这么慢了 忐忑中,,不是一个月就有结果吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a97104148, createdName=yufeng00000, createdTime=Sun Jun 15 17:42:00 CST 2014, time=2014-06-15, status=1, ipAttribution=)]
    2015-11-20 mileo

    接受率大概多少?好像是10%左右吧。。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=536282, encodeId=8a81536282d4, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇,审稿一个月,三个审稿意见,均为小修。希望能接受!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3582, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78021615620, createdName=xibo2007, createdTime=Tue May 02 22:30:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529256, encodeId=57065292567f, content=接受了吗?<span class="quote">yanyinkun 2015-07-21 发表::<br>研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!</span>, beContent=yanyinkun 2015-07-21 发表:: 研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Nov 12 12:53:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522496, encodeId=755452249678, content=审稿速度:1.0<br>经验分享:大牛杂志,提了一堆修改意见,之后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Tue May 17 02:05:00 CST 2016, time=2016-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831968, encodeId=025c831968b5, content=审稿速度:1.0<br>经验分享:在这个期刊已经接受了两篇,还有一篇小修,感觉办事效率很高,基本两星期审稿意见回来,修改后基本一周内接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Apr 14 10:50:43 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519202, encodeId=2ed251920296, content=你是幸运儿之一吗?<span class="quote">mileo 2015-11-20 发表::<br>接受率大概多少?好像是10%左右吧。。</span>, beContent=mileo 2015-11-20 发表:: 接受率大概多少?好像是10%左右吧。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Mon Feb 15 09:02:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516955, encodeId=2709516955fb, content=接受率大概多少?好像是10%左右吧。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Fri Nov 20 01:16:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513707, encodeId=b01c513e0716, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿50天,还在under review. 估计该回信了,着急啊!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c4a23377, createdName=yanyinkun, createdTime=Tue Jul 21 22:01:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513632, encodeId=eddd51363295, content=投稿命中率:5.0<br>经验分享:投了Circulationb被拒,改投JACC,有关心肌停跳液心肌保护的回顾性和随访研究,审稿一个多月,两个审稿人均拒绝了,文章创新性不够,说现在北美流行的是 del Nido液,为何不比较HTK和del Nido液的临床结果?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=677, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Jul 18 22:26:00 CST 2015, time=2015-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510801, encodeId=e86851080124, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇文章,审了26天,被拒,但审稿意见非常细,非常有用,建议时间不紧张的可以多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat Mar 28 20:55:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503572, encodeId=8de25035e24b, content=投了一篇 审稿47天了 怎么变得这么慢了 忐忑中,,不是一个月就有结果吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a97104148, createdName=yufeng00000, createdTime=Sun Jun 15 17:42:00 CST 2014, time=2014-06-15, status=1, ipAttribution=)]
    2015-07-21 yanyinkun

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:投稿50天,还在under review. 估计该回信了,着急啊!!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=536282, encodeId=8a81536282d4, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇,审稿一个月,三个审稿意见,均为小修。希望能接受!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3582, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78021615620, createdName=xibo2007, createdTime=Tue May 02 22:30:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529256, encodeId=57065292567f, content=接受了吗?<span class="quote">yanyinkun 2015-07-21 发表::<br>研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!</span>, beContent=yanyinkun 2015-07-21 发表:: 研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Nov 12 12:53:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522496, encodeId=755452249678, content=审稿速度:1.0<br>经验分享:大牛杂志,提了一堆修改意见,之后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Tue May 17 02:05:00 CST 2016, time=2016-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831968, encodeId=025c831968b5, content=审稿速度:1.0<br>经验分享:在这个期刊已经接受了两篇,还有一篇小修,感觉办事效率很高,基本两星期审稿意见回来,修改后基本一周内接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Apr 14 10:50:43 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519202, encodeId=2ed251920296, content=你是幸运儿之一吗?<span class="quote">mileo 2015-11-20 发表::<br>接受率大概多少?好像是10%左右吧。。</span>, beContent=mileo 2015-11-20 发表:: 接受率大概多少?好像是10%左右吧。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Mon Feb 15 09:02:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516955, encodeId=2709516955fb, content=接受率大概多少?好像是10%左右吧。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Fri Nov 20 01:16:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513707, encodeId=b01c513e0716, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿50天,还在under review. 估计该回信了,着急啊!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c4a23377, createdName=yanyinkun, createdTime=Tue Jul 21 22:01:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513632, encodeId=eddd51363295, content=投稿命中率:5.0<br>经验分享:投了Circulationb被拒,改投JACC,有关心肌停跳液心肌保护的回顾性和随访研究,审稿一个多月,两个审稿人均拒绝了,文章创新性不够,说现在北美流行的是 del Nido液,为何不比较HTK和del Nido液的临床结果?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=677, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Jul 18 22:26:00 CST 2015, time=2015-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510801, encodeId=e86851080124, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇文章,审了26天,被拒,但审稿意见非常细,非常有用,建议时间不紧张的可以多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat Mar 28 20:55:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503572, encodeId=8de25035e24b, content=投了一篇 审稿47天了 怎么变得这么慢了 忐忑中,,不是一个月就有结果吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a97104148, createdName=yufeng00000, createdTime=Sun Jun 15 17:42:00 CST 2014, time=2014-06-15, status=1, ipAttribution=)]
    2015-07-18 b2007117

    投稿命中率:5.0
    经验分享:投了Circulationb被拒,改投JACC,有关心肌停跳液心肌保护的回顾性和随访研究,审稿一个多月,两个审稿人均拒绝了,文章创新性不够,说现在北美流行的是 del Nido液,为何不比较HTK和del Nido液的临床结果?

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=536282, encodeId=8a81536282d4, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇,审稿一个月,三个审稿意见,均为小修。希望能接受!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3582, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78021615620, createdName=xibo2007, createdTime=Tue May 02 22:30:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529256, encodeId=57065292567f, content=接受了吗?<span class="quote">yanyinkun 2015-07-21 发表::<br>研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!</span>, beContent=yanyinkun 2015-07-21 发表:: 研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Nov 12 12:53:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522496, encodeId=755452249678, content=审稿速度:1.0<br>经验分享:大牛杂志,提了一堆修改意见,之后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Tue May 17 02:05:00 CST 2016, time=2016-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831968, encodeId=025c831968b5, content=审稿速度:1.0<br>经验分享:在这个期刊已经接受了两篇,还有一篇小修,感觉办事效率很高,基本两星期审稿意见回来,修改后基本一周内接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Apr 14 10:50:43 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519202, encodeId=2ed251920296, content=你是幸运儿之一吗?<span class="quote">mileo 2015-11-20 发表::<br>接受率大概多少?好像是10%左右吧。。</span>, beContent=mileo 2015-11-20 发表:: 接受率大概多少?好像是10%左右吧。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Mon Feb 15 09:02:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516955, encodeId=2709516955fb, content=接受率大概多少?好像是10%左右吧。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Fri Nov 20 01:16:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513707, encodeId=b01c513e0716, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿50天,还在under review. 估计该回信了,着急啊!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c4a23377, createdName=yanyinkun, createdTime=Tue Jul 21 22:01:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513632, encodeId=eddd51363295, content=投稿命中率:5.0<br>经验分享:投了Circulationb被拒,改投JACC,有关心肌停跳液心肌保护的回顾性和随访研究,审稿一个多月,两个审稿人均拒绝了,文章创新性不够,说现在北美流行的是 del Nido液,为何不比较HTK和del Nido液的临床结果?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=677, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Jul 18 22:26:00 CST 2015, time=2015-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510801, encodeId=e86851080124, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇文章,审了26天,被拒,但审稿意见非常细,非常有用,建议时间不紧张的可以多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat Mar 28 20:55:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503572, encodeId=8de25035e24b, content=投了一篇 审稿47天了 怎么变得这么慢了 忐忑中,,不是一个月就有结果吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a97104148, createdName=yufeng00000, createdTime=Sun Jun 15 17:42:00 CST 2014, time=2014-06-15, status=1, ipAttribution=)]
    2015-03-28 arlian1977

    审稿速度:1.0 | 投稿命中率:5.0
    经验分享:投了一篇文章,审了26天,被拒,但审稿意见非常细,非常有用,建议时间不紧张的可以多投

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=536282, encodeId=8a81536282d4, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇,审稿一个月,三个审稿意见,均为小修。希望能接受!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3582, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78021615620, createdName=xibo2007, createdTime=Tue May 02 22:30:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529256, encodeId=57065292567f, content=接受了吗?<span class="quote">yanyinkun 2015-07-21 发表::<br>研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!</span>, beContent=yanyinkun 2015-07-21 发表:: 研究方向:心血管;肥胖;高血压 接收率:约25% 审稿时间:约2个月 投稿50天,还在under review. 估计该回信了,着急啊!!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Nov 12 12:53:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522496, encodeId=755452249678, content=审稿速度:1.0<br>经验分享:大牛杂志,提了一堆修改意见,之后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=478, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Tue May 17 02:05:00 CST 2016, time=2016-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831968, encodeId=025c831968b5, content=审稿速度:1.0<br>经验分享:在这个期刊已经接受了两篇,还有一篇小修,感觉办事效率很高,基本两星期审稿意见回来,修改后基本一周内接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Thu Apr 14 10:50:43 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519202, encodeId=2ed251920296, content=你是幸运儿之一吗?<span class="quote">mileo 2015-11-20 发表::<br>接受率大概多少?好像是10%左右吧。。</span>, beContent=mileo 2015-11-20 发表:: 接受率大概多少?好像是10%左右吧。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=585, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67ce42087, createdName=pangshiwei, createdTime=Mon Feb 15 09:02:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516955, encodeId=2709516955fb, content=接受率大概多少?好像是10%左右吧。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=524, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Fri Nov 20 01:16:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513707, encodeId=b01c513e0716, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿50天,还在under review. 估计该回信了,着急啊!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c4a23377, createdName=yanyinkun, createdTime=Tue Jul 21 22:01:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513632, encodeId=eddd51363295, content=投稿命中率:5.0<br>经验分享:投了Circulationb被拒,改投JACC,有关心肌停跳液心肌保护的回顾性和随访研究,审稿一个多月,两个审稿人均拒绝了,文章创新性不够,说现在北美流行的是 del Nido液,为何不比较HTK和del Nido液的临床结果?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=677, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Jul 18 22:26:00 CST 2015, time=2015-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510801, encodeId=e86851080124, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了一篇文章,审了26天,被拒,但审稿意见非常细,非常有用,建议时间不紧张的可以多投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sat Mar 28 20:55:00 CST 2015, time=2015-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503572, encodeId=8de25035e24b, content=投了一篇 审稿47天了 怎么变得这么慢了 忐忑中,,不是一个月就有结果吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a97104148, createdName=yufeng00000, createdTime=Sun Jun 15 17:42:00 CST 2014, time=2014-06-15, status=1, ipAttribution=)]
    2014-06-15 yufeng00000

    投了一篇 审稿47天了 怎么变得这么慢了 忐忑中,,不是一个月就有结果吗?

    0

共45条页码: 2/5页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分